Stem cell transplantation and lung dysfunction

Current Opinion in Pediatrics

Volumn 25, Issue 3, 2013, Pages 350-356

  Haddad, Imad Y ^a  

^a Banner Children's Hospital   (United States)

Author keywords

Bronchiolitis obliterans; Graft versus host disease; Idiopathic pneumonia syndrome; Respiratory failure

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AZITHROMYCIN; CALCINEURIN INHIBITOR; CLARITHROMYCIN; COTRIMOXAZOLE; ETANERCEPT; FLUCONAZOLE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RITUXIMAB; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADAPTIVE IMMUNITY; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTIFICIAL VENTILATION; BRONCHIOLITIS OBLITERANS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CHEMORADIOTHERAPY; COMORBIDITY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE SEVERITY; EARLY DIAGNOSIS; ENGRAFTMENT SYNDROME; FLUID THERAPY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IDIOPATHIC PNEUMONIA SYNDROME; INCIDENCE; INNATE IMMUNITY; INTENSIVE CARE; LUNG ALVEOLUS; LUNG DISEASE; LUNG HEMORRHAGE; NEUTROPENIA; NONHUMAN; PATHOGENESIS; PNEUMONIA; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY VENO-OCCLUSIVE DISEASE; RESPIRATORY EPITHELIUM; RESPIRATORY FAILURE; RESPIRATORY TRACT INFECTION; REVIEW;

BRONCHIOLITIS OBLITERANS; EARLY DIAGNOSIS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LUNG DISEASES; PNEUMONIA;

EID: 84879984484     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e328360c317     Document Type: Review

References (41)

1. Kaya Z, Weiner DJ, Yilmaz D, et al. Lung function, pulmonary complications, and mortality after allogeneic blood and marrow transplantation in children. Biol Blood Marrow Transplant 2009; 15:817-826.
2. Tamburro RF, Barfield RC, Shaffer ML, et al. Changes in outcomes (1996-2004) for pediatric oncology and hematopoietic stem cell transplant patients requiring invasive mechanical ventilation. Pediatr Crit Care Med 2008; 9:270-277.
3. Gooley TA, Chien JW, Pergam SA, et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010; 363:2091-2101.
4. Bratton SL, Van Duker H, Statler KD, et al. Lower hospital mortality and complications after pediatric hematopoietic stem cell transplantation. Crit Care Med 2008; 36:923-927.
5. Panoskaltsis-Mortari A, Griese M, Madtes DK, et al. An official American Thoracic Society Research Statement. Noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. Am J Respir Crit Care Med 2011; 183:1262-1279.
6. Kharbanda S, Panoskaltsis-Mortari A, Haddad IY, et al. Inflammatory cytokines and the development of pulmonary complications after allogeneic hematopoietic cell transplantation in patients with inherited metabolic storage disorders. Biol Blood Marrow Transplant 2006; 12:430-437.
7. Smith AR, Gulbahce E, Burke MJ, et al. Lower leukemia relapse in pediatric patients with pulmonary cytolytic thrombi following allogeneic transplant. Bone Marrow Transplant 2011; 46:368-371.
8. Haddad IY, Wiryawan B. The spectrum of idiopathic pneumonia syndrome: risk factors, diagnosis, and treatment. Clin Pulm Med 2011; 18:70-76.
9. Tanaka N, Kunihiro Y, Yujiri T, et al. High-resolution computed tomography of chest in patients treated with hematopoietic stem cell transplantation. Jpn J Radiol 2011; 29:229-235.
10. Naiditch JA, Barsness KA, Rothstein DH. The utility of surgical lung biopsy in immune-compromised children. J Pediatr 2012; 162:133-136.
11. He H, Ding L, Sun B, et al. Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study. Crit Care 2012; 16:R138.
12. Tragiannidis A, Dokos C, Lehrnbecher T, Groll AH. Antifungal chemoprophylaxis in children and adolescents with hematological malignancies and following allogeneic hematopoietic stem cell transplantation: review of the literature and options for clinical practice. Drugs 2012; 72:685-704.
13. Ringdén O, Remberger M, Dahllöf G, et al. Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic hematopoietic stem cell transplantation for nonmalignant disorders. Eur J Haematol 2011; 87:503-509.
14. Liu QF, Luo XD, Ning J, et al. Association between acute graft versus host disease and lung injury after allogeneic hematopoietic stem cell transplantation. Hematology 2009; 14:63-72.
15. Park M, Koh KN, Kim BE, et al. Clinical features of late onset noninfectious pulmonary complications following pediatric allogeneic hematopoietic stem cell transplantation. Clin Transplant 2011; 25:E168-E176.
16. Sengsayadeth SM, Srivastava S, Jagasia M, Savani BN. Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2012; 18:1479-1487.
17. Gram K, Yang S, Steiner M, et al. Simultaneous absence of surfactant proteins A and D increases lung inflammation and injury after allogeneic HSCT in mice. Am J Physiol Lung Cell Mol Physiol 2009; 296:L167-L175.
18. Srinivasan M, Flynn R, Price A, et al. Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans. Blood 2012; 119:1570-1580.
19. Johnson BD. Exciting new murine model of cGVHD. Blood 2012; 119:1331-1332.
20. Huisman C, van der Straaten HM, Canninga-van Dijk MR, et al. Pulmonary complications after T-cell-depleted allogeneic stem cell transplantation: low incidence and strong association with acute graft-versus-host disease. Bone Marrow Transplant 2006; 38:561-566.
21. Ditschkowski M, Elmaagacli AH, Trenschel R, et al. T-cell depletion prevents from bronchiolitis obliterans and bronchiolitis obliterans with organizing pneumonia after allogeneic hematopoietic stem cell transplantation with related donors. Haematologica 2007; 92:558-561.
22. Yi ES, Lee SH, Son MH, et al. Hematopoietic stem cell transplantation in children with acute leukemia: similar outcomes in recipients of umbilical cord blood versus marrow or peripheral blood stem cells from related or unrelated donors. Korean J Pediatr 2012; 55:93-99.
23. Dudek AZ, Mahaseth H, DeFor TE, Weisdorf DJ. Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 2003; 9:657-666.
24. Fukuda T, Hackman RC, Guthrie KA, et al. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood 2003; 102:2777-2785.
25. Sampath S, Schultheiss TE, Wong J. Dose response and factors related to interstitial pneumonitis after bone marrow transplant. Int J Radiat Oncol Biol Phys 2005; 63:876-884.
26. Satwani P, Jin Z, Duffy D, et al. Transplant-related mortality, graft failure and survival following reduced toxicity conditioning and allogeneic hematopoietic stem cell transplantation in 100 consecutive pediatric recipients. Biol Blood Marrow Transplant 2013; 19:552-561.
27. Iguchi A, Kawamura N, Kobayashi R, et al. Successful reduced-intensity SCT from unrelated cord blood in three patients with X-linked SCID. Bone Marrow Transplant 2011; 46:1526-1531.
28. Locatelli F, Pagliara D. Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease. Pediatr Blood Cancer 2012; 59:372-376.
29. Turner DA, Arnold JH. Insights in pediatric ventilation: timing of intubation, ventilatory strategies, and weaning. Curr Opin Crit Care 2007; 13: 57-63.
30. Faqih NA, Qabba'h SH, Rihani RS, et al. The use of high frequency oscillatory ventilation in a pediatric oncology intensive care unit. Pediatr Blood Cancer 2012; 58:384-389.
31. Wermke M, Schiemanck S, Hoffken G, et al. Respiratory failure in patients undergoing allogeneic hematopoietic SCT: a randomized trial on early noninvasive ventilation based on standard care hematology wards. Bone Marrow Transplant 2012; 47:574-580.
32. Arikan AA, Zappitelli M, Goldstein SL, et al. Fluid overload is associated with impaired oxygenation and morbidity in critically ill children. Pediatr Crit Care Med 2012; 13:253-258.
33. Benoit G, Phan V, Duval M, et al. Fluid balance of pediatric hematopoietic stem cell transplant recipients and intensive care unit admission. Pediatr Nephrol 2007; 22:441-447.
34. Valentine SL, Sapru A, Higgerson RA, et al. Fluid balance in critically ill children with acute lung injury. Crit Care Med 2012; 40:2883-2889.
35. Elbahlawan L, Morrison RR. Continuous renal replacement therapy in children posthematopoietic stem cell transplantation: the present and the future. Curr Stem Cell Res Ther 2012; 7:381-387.
36. McArthur J, Pettersen G, Jouvet P, et al. The care of critically ill children after hematopoietic SCT: a North American survey. Bone MarrowTransplant 2011; 46:227-231.
37. Lemonnier F, Dhedin N, Catherinot E, et al. Bronchiolitis obliterans postallogeneic stem cell transplantation: what is new? Rev Pneumol Clin 2011; 67:258-266.
38. Tizon R, Frey N, Heitjan DF, et al. High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT. Bone Marrow Transplant 2012; 47:1332-1337.
39. Hansmann G, Fernandez-Gonzalez A, Aslam M, et al. Mesenchymal stem cellmediated reversal of broncho-pulmonary dysplasia and associated pulmonary hypertension. Pulm Circ 2012; 2:170-181.
40. Tsai HL, Chang JW, Yang HW, et al. Amelioration of paraquat-induced pulmonary injury by mesenchymal stem cells. Cell Transplant 2012. [Epub ahead of print].
41. Raza K, Price AP, Matson A, et al. MSC therapy for obliterative bronchiolitis. Am J Resp Crit Care Med 2011; 183:A5289.